Debiopharm Revolutionizes Antibiotic Development with Debio 1453 Trial Against Gonorrhea
Debiopharm initiates first-in-human trial for Debio 1453, a novel antibiotic against gonorrhea, pushing innovation boundaries…
Debiopharm initiates first-in-human trial for Debio 1453, a novel antibiotic against gonorrhea, pushing innovation boundaries…
A significant increase in gonorrhea, syphilis, and chlamydia cases has been reported in Ireland, prompting…